Skip to main content

A Pivotal Study of the Premia Spine TOPS™ System

Completed · Not applicable · NCT03012776

Conditions: Lumbar Spinal Stenosis, Degenerative Spondylolisthesis

At a glance

Research payments reported, 2025
$510,229
U.S. investigators named
26
Sites paid
27
Planned or actual enrollment
305

About the trial

Sponsor
Premia Spine
Tested
Total Posterior Spine System (TOPS) (device), Transforaminal Lumbar Interbody Fusion (TLIF) (procedure)
Dates
Started 2017-07-17; completion 2023-06-14
Results posted
Not yet

The purpose of this trial is to assess whether the Total Posterior Spine System (TOPS System) is more effective than transforaminal lumbar interbody fusion (TLIF) when used to stabilize a single lumbar level (L2 - L5) following surgical decompression in patients diagnosed with (1) at least moderate lumbar spinal stenosis, and (2) Grade 1 spondylolisthesis (or retrolisthesis), and (3) thickening of the ligamentum flavum or scarring of the facet joint capsule. Success will be assessed by means of a composite endpoint that measures improvement in in patient reported outcomes and the absence of any major device related complications.

From ClinicalTrials.gov, last updated 2024-06-17. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Premia Spine, Ltd. reported $510,229 in research payments for this study in 2025 (72 payments).

Products named: Tops

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.